Chair

Tania Bubela

University of Alberta

Pre-Discussion Presentation

Katherine Bonter

Director of Commercialization Research, Personalized Cellular Immunotherapy Project, Hôpital Maisonneuve Rosemont

Panelists

Carmela De Luca

Partner, Bereskin & Parr LLP

Chris Wagner

President and Chief Executive Officer, Contextual Genomics, Inc.

Mel Krajden

Medical Director, Public Health Serology, Provinical Health Services Laboratories, BC Centre for Disease Control

Brad Popovich

Chief Scientific Officer, Genome British Columbia

This session will explore challenges in late-stage molecular diagnostics development, current best practices and strategies for enabling innovation in molecular diagnostics and personalized medicine. Stakeholder perspectives related to IP protection, technology transfer, investment, commercialization and health care system adoption will be shared and discussed, including both private- and public-sector views. To allow for interactive discussion between the panel members and the audience, the session will be run with minimal time devoted to formal presentations.